Medical Letter On Drugs And Therapeutics

Journal Title：Medical Letter On Drugs And Therapeutics

The Medical Letter, Inc. is committed to providing objective, practical, and timely information on drugs and treatments of common diseases to help our readers make the best decisions for their patients—without the influence of the pharmaceutical industry.

The Medical Letter On Drugs and Therapeutics is a biweekly publication that provides:

Evidence-based, peer-reviewed evaluations of new FDA-approved drugs with conclusions reached by a consensus of experts

New information on previously approved drugs including pivotal clinical trials, new indications, and safety warnings

Consensus recommendations for the preferred and alternative treatments for common disorders

Comparative reviews of drugs for a given indication with particular attention to clinical efficacy, adverse effects, drug interactions, and cost.

《医学快报》致力于提供客观、实用、及时的常见疾病药物和治疗信息，帮助我们的读者为患者做出最佳决策，不受制药行业的影响。

《医学快报：药物和治疗学》是一份双周刊，提供：

基于证据、同行评审的 FDA 批准新药评估，结论由专家达成共识

有关先前批准药物的新信息，包括关键临床试验、新适应症和安全警告

常见疾病首选和替代治疗的共识建议

针对特定适应症的药物进行比较性评价，特别关注临床疗效、不良反应、药物相互作用和成本。

Medical Letter On Drugs And Therapeutics创刊于1959年，由Medical Letter Inc.出版商出版，收稿方向涵盖医学 - 药学全领域，此期刊水平偏中等偏靠后，在所属细分领域中专业影响力一般，过审相对较易，如果您文章质量佳，选择此期刊，发表机率较高。平均审稿速度 较慢,6-12周 ，影响因子指数1.4，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。